Multidisciplinary Approach to the Child with Sex Chromosomal Mosaicism Including a Y-Containing Cell Line

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2021 Jan 26

PMID 33494433

Citations 2

Authors

Bauke Debo

Marlies Van Loocke

Katya De Groote

Els De Leenheer

Martine Cools

Affiliations

Soon will be listed here.

Abstract

Children born with sex chromosomal mosaicism including material derived from the Y chromosome may present with a broad phenotypical spectrum. Both boys and girls can present with Turner features and functional health problems typically associated with Turner syndrome, but the presence of Y-chromosomal material can modify some aspects of the condition. We retrospectively analyzed the results of our cohort of 21 individuals (14 boys, 7 girls) with sex chromosomal mosaicism including Y-derived material followed at Ghent University Hospital according to our local multidisciplinary Turner surveillance protocol. Results were compared with literature data, focusing on similarities and differences between girls and boys with this condition. Age at diagnosis was lower in boys compared to girls but the difference was not significant. Short stature is a key feature of the condition both in girls and boys, but skeletal maturation may be different between groups. The effects of growth-hormone therapy remain unclear. Cardiac (33%), ear-nose- throat (ENT) (77.8%) and renal (28.6%) problems were as prevalent in boys as in girls from our cohort, and did not differ from literature data. In line with literature reports, a significant difference in the presence of premalignant germ cell tumors between males (0%) and females (42.9%) was found ( = 0.026). Taken together, this study demonstrates the similarities between girls with Turner syndrome and children with sex chromosomal mosaicism including Y-derived material, regardless of the child's gender. Nowadays, girls with Turner syndrome are offered a dedicated multidisciplinary follow-up in many centers. We advocate a similar follow-up program for all children who have sex chromosomal mosaicism that includes Y-derived material, with special attention to growth, cardiac and ear-nose-throat problems, gonadal function and malignancies.

Citing Articles

Human embryonic genetic mosaicism and its effects on development and disease.

Waldvogel S, Posey J, Goodell M Nat Rev Genet. 2024; 25(10):698-714.

PMID: 38605218 PMC: 11408116. DOI: 10.1038/s41576-024-00715-z.

Individuals with numerical and structural variations of sex chromosomes: interdisciplinary management with focus on fertility potential.

Juul A, Gravholt C, De Vos M, Koledova E, Cools M Front Endocrinol (Lausanne). 2023; 14:1160884.

PMID: 37214245 PMC: 10197804. DOI: 10.3389/fendo.2023.1160884.

References

Rosa R, DEcclesiis W, Dibbi R, Rosa R, Trevisan P, Graziadio C . 45,X/46,XY mosaicism: report on 14 patients from a Brazilian hospital. A retrospective study. Sao Paulo Med J. 2014; 132(6):332-8. PMC: 10496778. View

Huang Y, Lee C, Wu M, Liu S, Tung Y, Ho H . The spectrum of 45,X/46,XY mosaicism in Taiwanese children: The experience of a single center. J Formos Med Assoc. 2018; 118(1 Pt 3):450-456. DOI: 10.1016/j.jfma.2018.07.003. View

Gravholt C, Andersen N, Conway G, Dekkers O, Geffner M, Klein K . Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017; 177(3):G1-G70. DOI: 10.1530/EJE-17-0430. View

De Groote K, Cools M, De Schepper J, Craen M, Francois I, Devos D . Cardiovascular pathology in males and females with 45,X/46,XY mosaicism. PLoS One. 2013; 8(2):e54977. PMC: 3573040. DOI: 10.1371/journal.pone.0054977. View

van der Zwan Y, Biermann K, Wolffenbuttel K, Cools M, Looijenga L . Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model. Eur Urol. 2014; 67(4):692-701. DOI: 10.1016/j.eururo.2014.07.011. View

Kersemaekers A, Honecker F, Stoop H, Cools M, Molier M, Wolffenbuttel K . Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol. 2005; 36(5):512-21. DOI: 10.1016/j.humpath.2005.02.016. View

Richter-Unruh A, Knauer-Fischer S, Kaspers S, Albrecht B, Gillessen-Kaesbach G, Hauffa B . Short stature in children with an apparently normal male phenotype can be caused by 45,X/46,XY mosaicism and is susceptible to growth hormone treatment. Eur J Pediatr. 2004; 163(4-5):251-6. DOI: 10.1007/s00431-004-1406-0. View

Roelants M, Hauspie R, Hoppenbrouwers K . References for growth and pubertal development from birth to 21 years in Flanders, Belgium. Ann Hum Biol. 2009; 36(6):680-94. DOI: 10.3109/03014460903049074. View

Slowikowska-Hilczer J, Linden Hirschberg A, Claahsen-van der Grinten H, Reisch N, Bouvattier C, Thyen U . Fertility outcome and information on fertility issues in individuals with different forms of disorders of sex development: findings from the dsd-LIFE study. Fertil Steril. 2017; 108(5):822-831. DOI: 10.1016/j.fertnstert.2017.08.013. View

10.

van der Straaten S, Springer A, Zecic A, Hebenstreit D, Tonnhofer U, Gawlik A . The External Genitalia Score (EGS): A European Multicenter Validation Study. J Clin Endocrinol Metab. 2019; 105(3). DOI: 10.1210/clinem/dgz142. View

11.

Hook E, Warburton D . Turner syndrome revisited: review of new data supports the hypothesis that all viable 45,X cases are cryptic mosaics with a rescue cell line, implying an origin by mitotic loss. Hum Genet. 2014; 133(4):417-24. DOI: 10.1007/s00439-014-1420-x. View

12.

Akinsal E, Baydilli N, Bayramov R, Ekmekcioglu O . A Rare Cause of Male Infertility: 45,X/46,XY Mosaicism. Urol Int. 2017; 101(4):481-485. DOI: 10.1159/000484615. View

13.

Bertelloni S, Baroncelli G, Massart F, Toschi B . Growth in Boys with 45,X/46,XY Mosaicism: Effect of Growth Hormone Treatment on Statural Growth. Sex Dev. 2015; 9(4):183-9. DOI: 10.1159/000441342. View

14.

Matsumoto F, Matsuyama S, Matsui F, Yazawa K, Matsuoka K . Variation of Gonadal Dysgenesis and Tumor Risk in Patients With 45,X/46,XY Mosaicism. Urology. 2019; 137:157-160. DOI: 10.1016/j.urology.2019.12.014. View

15.

Andrade J, Fabbri-Scallet H, Dos Santos A, Cools M, Werner R, Hiort O . Clinical Findings and Follow-Up of 46,XY and 45,X/46,XY Testicular Dysgenesis. Sex Dev. 2019; 13(4):171-177. DOI: 10.1159/000504239. View

16.

Cools M, Boter M, van Gurp R, Stoop H, Poddighe P, Lau Y . Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads. Clin Endocrinol (Oxf). 2007; 67(2):184-92. DOI: 10.1111/j.1365-2265.2007.02859.x. View

17.

Li Y, Vilain E, Conte F, Rajpert-De Meyts E, Lau Y . Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ. Urol Oncol. 2007; 25(2):141-6. DOI: 10.1016/j.urolonc.2006.08.002. View

18.

Tosson H, Rose S, Gartner L . Description of children with 45,X/46,XY karyotype. Eur J Pediatr. 2011; 171(3):521-9. DOI: 10.1007/s00431-011-1600-9. View

19.

Cools M, Looijenga L, Wolffenbuttel K, TSjoen G . Managing the risk of germ cell tumourigenesis in disorders of sex development patients. Endocr Dev. 2014; 27:185-96. DOI: 10.1159/000363642. View

20.

Dumeige L, Chatelais L, Bouvattier C, de Kerdanet M, Hyon C, Esteva B . Should 45,X/46,XY boys with no or mild anomaly of external genitalia be investigated and followed up?. Eur J Endocrinol. 2018; 179(3):181-190. DOI: 10.1530/EJE-18-0309. View